'Gut health': a new objective in medicine?
Open accessThe DOI matches its Crossref record; 146 of the 147 references it cites were found in a registry or an index.
Abstract
'Gut health' is a term increasingly used in the medical literature and by the food industry. It covers multiple positive aspects of the gastrointestinal (GI) tract, such as the effective digestion and absorption of food, the absence of GI illness, normal and stable intestinal microbiota, effective immune status and a state of well-being. From a scientific point of view, however, it is still extremely unclear exactly what gut health is, how it can be defined and how it can be measured. The GI barrier adjacent to the GI microbiota appears to be the key to understanding the complex mechanisms that maintain gut health. Any impairment of the GI barrier can increase the risk of developing infectious, inflammatory and functional GI diseases, as well as extraintestinal diseases such as immune-mediated and metabolic disorders. Less clear, however, is whether GI discomfort in general can also be related to GI barrier functions. In any case, methods of assessing, improving and maintaining gut health-related GI functions are of major interest in preventive medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 2×
“The permanent challenge of bacterial antigens to the mucosal immune system is required for its normal development and function [24,25].”
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 1×
“It may be helpful to combine such questionnaires with, for example, the Gastrointestinal Symptom Rating Scale, consisting of 15 questions on symptoms [75], or the Bristol Stool Scale, which classifies the form of human faeces into seven categories, with types 1 and 2 indicating constipation, types 3 and 4 being the ‘i…”
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · cited 1×
“For example, the stressinduced adrenocorticotropin hormone response in animals is much more pronounced in germ-free mice than in colonised animals [57].”
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 2×
“In all the individuals tested in one study [33], the taxonomic composition of the flora closely resembled its pretreatment state four weeks after antibiotic treatment had finished, but there were several taxa that failed to recover within six months.”
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 5×
“Most important, it contributes to the maintenance of an intact GI barrier, which seems to be closely related to infectious, inflammatory and allergic diseases [20,30].”
InfluentialCani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,774 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 1×
“Other disease-related GI symptom scales that have been validated are the IBS Severity Scoring System for scoring lower GI tract symptoms and the Leeds Dyspepsia Questionnaire or the Gastrointestinal Symptom profile for scoring upper GI tract symptoms [77-79].”
The burden and costs of chronic diseases in low-income and middle-income countries.
Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M., & Strong, K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61696-1 · Cited by 1,603 · cited 1×
“therefore, we must draw more attention to the maintenance of health, and this includes gut health [110-113].”
Gershon, M. D., & Tack, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.002 · Cited by 1,563
Allergy, Parasites, and the Hygiene Hypothesis
Yazdanbakhsh, M., Kremsner, P. G., & van Ree, R. (2002) · Science · doi:10.1126/science.296.5567.490 · Cited by 1,526 · cited 1×
“This concept maintains that any disturbance of the balance between the microbiome and the mucosal immune system will lead to impairment of the GI barrier and subsequently to an increased risk to gut health and subsequent development of GI disease [53,86-88].”
Svedlund, J., Sj�din, I., & Dotevall, G. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01535722 · Cited by 1,468 · cited 1×
“It may be helpful to combine such questionnaires with, for example, the Gastrointestinal Symptom Rating Scale, consisting of 15 questions on symptoms [75], or the Bristol Stool Scale, which classifies the form of human faeces into seven categories, with types 1 and 2 indicating constipation, types 3 and 4 being the ‘i…”
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466 · cited 1×
“and antibodies) and innate immune cells such as macrophages and mast cells (via TLRs and other PRRs) are also involved in communication between the GI microbiome and the GI immune system so that any danger from pathogens can be recognised and also to maintain the friendly coexistence of bacteria and host in the gut [4…”
Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01620.x · Cited by 1,392 · cited 1×
“Of particular interest in this context is the recent finding in germ-free mice that the gut microbiota can directly influence not only GI functions but also the development of behaviour and corresponding neurochemical changes in the brain [16].”
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346 · cited 1×
“Indeed, it has been shown that chronic bowel diseases such as IBD are associated with adherence of commensal bacteria to the otherwise sterile intestinal epithelium [101] and that selected probiotics can prevent the adhesion of pathogenic bacteria to the intestinal mucosa [102] or restore leaky gut by improving the mo…”
Principles and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · cited 1×
“In particular, the GI barrier, and consequently gut health, will be directly altered not only by local disturbances (such as increased epithelial permeability due to infection or any loss of function of particular immune cells and their mediators) but also by any systemic burden such as reduced oxygenation in intensiv…”
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
A new measure of health status for clinical trials in inflammatory bowel disease
Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., & Tompkins, C. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90905-0 · Cited by 1,298 · cited 1×
“One such questionnaire is the Inflammatory Bowel Disease Questionnaire (IBDQ), a validated and reliable tool used to measure health-related quality of life (HRQoL) in adult patients with IBD, ulcerative colitis and Crohn’s disease [70].”
Evidence-Based Public Health: A Fundamental Concept for Public Health Practice
Brownson, R. C., Fielding, J. E., & Maylahn, C. M. (2009) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.031308.100134 · Cited by 1,124 · cited 1×
“therefore, we must draw more attention to the maintenance of health, and this includes gut health [110-113].”
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
Bouskra, D., Brézillon, C., Bérard, M., Werts, C., Varona, R., Boneca, I. G., & Eberl, G. (2008) · Nature · doi:10.1038/nature07450 · Cited by 1,107 · cited 3×
“The permanent challenge of bacterial antigens to the mucosal immune system is required for its normal development and function [24,25].”
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Microbial community profiling for human microbiome projects: Tools, techniques, and challenges
Hamady, M., & Knight, R. (2009) · Genome Research · doi:10.1101/gr.085464.108 · Cited by 1,001 · cited 2×
“Further establishment of diagnostic means to assess quickly and accurately the GI microbiome composition using molecular techniques will in the future allow us not only to describe in more detail the multiple relationships between the colonic microbiota and poor gut health but also to assess the impact of intervention…”
The core gut microbiome, energy balance and obesity
Turnbaugh, P. J., & Gordon, J. I. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.174136 · Cited by 993 · cited 2×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 864 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Sonnenburg, E. D., Zheng, H., Joglekar, P., Higginbottom, S. K., Firbank, S. J., Bolam, D. N., & Sonnenburg, J. L. (2010) · Cell · doi:10.1016/j.cell.2010.05.005 · Cited by 748 · cited 1×
“Any impairment of the GI microbiome, for example, by administration of oral antibiotics [31-33] or by an unbalanced diet such as a carbohydrate-rich diet [34,35], and SCB, (unpublished work), will affect the functionality of the host’s local defence systems.”
Bischoff, S. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2018 · Cited by 620 · cited 1×
“It monitors luminal conditions via sensory receptors and primary afferent neurons activated by secretagogues from enterochromaffin cells or mast cells such as biogenic amines (serotonin and histamine) or proteases [55,56].”
Self-citationPathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 2×
“The first hints that CNS diseases such as hepatic encephalopathy, depression and autism spectrum disorder might be treated by modulating the GI microbiome (for example, with the prebiotic and laxative lactulose, sugar-reduced diets or antibiotics) is a further argument for the relevance of the GBA [58-60].”
Collins, S. M., & Bercik, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.075 · Cited by 612 · cited 2×
“The ENS is strikingly independent from the central nervous system (CNS), yet it regulates almost all major functions of the gut, such as epithelial secretion, absorption and permeability; immune functions; and, as shown most recently, even the GI microbiota [40,41].”
Nutritional management of gut health in pigs around weaning
Lallès, J.-P., Bosi, P., Smidt, H., & Stokes, C. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005484 · Cited by 567 · cited 1×
“The expression ‘gut health’ lacks clear definition in the scientific literature, although it has been used repeatedly in human medicine [4-7] and in animal health [8,9].”
Camilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02033-x · Cited by 556 · cited 1×
“In clinical trials, overall improvement of symptoms has been assessed by using singular global questions such as the IBS Global Assessment of Improvement or the Subject’s Global Assessment of Relief, which have yielded reliable results [83,84].”
The Biology of Intestinal Immunoglobulin A Responses
Cerutti, A., & Rescigno, M. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.001 · Cited by 547 · cited 1×
“To achieve the defence of the host against luminal bacteria and other potentially harmful substances, the GI immune system is equipped with specific tools, such as the plasma cell-dependent immunoglobulin A (IgA) defence system, goblet cell-derived mucus production and the synthesis of antimicrobial peptides such as d…”
Preidis, G. A., & Versalovic, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.072 · Cited by 485 · cited 4×
“Further establishment of diagnostic means to assess quickly and accurately the GI microbiome composition using molecular techniques will in the future allow us not only to describe in more detail the multiple relationships between the colonic microbiota and poor gut health but also to assess the impact of intervention…”
InfluentialFasano, A., & Shea-Donohue, T. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0259 · Cited by 484 · cited 2×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Diagnosing and Managing Common Food Allergies: A Systematic Review
Chafen, J. J. S., Newberry, S. J., Riedl, M. A., Bravata, D. M., Maglione, M., Suttorp, M. J., Sundaram, V., Paige, N. M., Towfigh, A., Hulley, B. J., et al. (2010) · JAMA · doi:10.1001/jama.2010.582 · Cited by 482 · cited 1×
“Therefore, a balanced diet that includes high vegetable and fibre content and moderate consumption of red meat to prevent colon cancer [92,93], or an individualized elimination diet in selected individuals with food intolerances, food allergy or coeliac disease [94,95], might contribute to gut health.”
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482 · cited 1×
“Indeed, it has been shown that chronic bowel diseases such as IBD are associated with adherence of commensal bacteria to the otherwise sterile intestinal epithelium [101] and that selected probiotics can prevent the adhesion of pathogenic bacteria to the intestinal mucosa [102] or restore leaky gut by improving the mo…”
Gut microbiota: a potential new territory for drug targeting
Jia, W., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 475 · cited 1×
“The use of such tools in daily practice for diagnostic purposes and for new drug development [127], together with improved communication about gut issues as proposed by several national initiatives in the United Kingdom [128], the Netherlands [129] and Germany (initiative of the Felix-Burda foundation; see http://www.”
tana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01427.x · Cited by 474 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Managing gut health through nutrition
Choct, M. (2009) · British Poultry Science · doi:10.1080/00071660802538632 · Cited by 433 · cited 1×
“The expression ‘gut health’ lacks clear definition in the scientific literature, although it has been used repeatedly in human medicine [4-7] and in animal health [8,9].”
Fecal microbiota in early rheumatoid arthritis.
Vaahtovuo, J., Munukka, E., Korkeamäki, M., Luukkainen, R., & Toivanen, P. (2008) · PubMed · Cited by 426
Immune Responses to the Microbiota at the Intestinal Mucosal Surface
Duerkop, B. A., Vaishnava, S., & Hooper, L. V. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.009 · Cited by 424 · cited 1×
“To achieve the defence of the host against luminal bacteria and other potentially harmful substances, the GI immune system is equipped with specific tools, such as the plasma cell-dependent immunoglobulin A (IgA) defence system, goblet cell-derived mucus production and the synthesis of antimicrobial peptides such as d…”
Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease1,
Blaut, M., & Clavel, T. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.751s · Cited by 420 · cited 2×
“The details of how the gut has an impact on health in general have been reviewed in detail elsewhere [1,11-15] and are summarised in Figure 1.”
Using probiotics and prebiotics to improve gut health
Tuohy, K. M., Probert, H. M., Smejkal, C. W., & Gibson, G. R. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02746-6 · Cited by 420 · cited 2×
“The expression ‘gut health’ lacks clear definition in the scientific literature, although it has been used repeatedly in human medicine [4-7] and in animal health [8,9].”
Tanaka, S., Kobayashi, T., Songjinda, P., Tateyama, A., Tsubouchi, M., Kiyohara, C., Shirakawa, T., Sonomoto, K., & Nakayama, J. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00553.x · Cited by 397 · cited 1×
“Any impairment of the GI microbiome, for example, by administration of oral antibiotics [31-33] or by an unbalanced diet such as a carbohydrate-rich diet [34,35], and SCB, (unpublished work), will affect the functionality of the host’s local defence systems.”
The mechanism of action of probiotics
Boirivant, M., & Strober, W. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f0cffc · Cited by 380 · cited 1×
“Moreover, the mechanism of activity for probiotics inside and beyond the gut is also far from clear [122,123].”
Altered early infant gut microbiota in children developing allergy up to 5 years of age
Sjögren, Y. M., Jenmalm, M. C., Böttcher, M. F., Björkstén, B., & Sverremark‐Ekström, E. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03156.x · Cited by 378 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., & Tappy, L. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27336 · Cited by 369 · cited 2×
“On the other hand, dietary changes have been shown to help prevent major diseases such as allergy, obesity and cancer [20,90,91].”
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362 · cited 1×
“Probiotic intervention, however, still needs to be improved [120,121].”
Mechanisms of hypersensitivity in IBS and functional disorders
Azpiroz, F., Bouin, M., Camilleri, M., Mayer, E. A., Poitras, P., Serra, J., & Spiller, R. C. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00875.x · Cited by 354 · cited 2×
“Although a few IBS studies on familial associations and gene polymorphisms have suggested that genetic factors might play a role in the pathogenesis of this disease [63,64], the converse argument that genetic factors determine gut health is not justified yet.”
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
Cario, E. (2005) · Gut · doi:10.1136/gut.2004.062794 · Cited by 351 · cited 1×
“and antibodies) and innate immune cells such as macrophages and mast cells (via TLRs and other PRRs) are also involved in communication between the GI microbiome and the GI immune system so that any danger from pathogens can be recognised and also to maintain the friendly coexistence of bacteria and host in the gut [4…”
The environment within: how gut microbiota may influence metabolism and body composition
Vrieze, A., Holleman, F., Zoetendal, E. G., de Vos, W. M., Hoekstra, J. B. L., & Nieuwdorp, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1662-7 · Cited by 343 · cited 2×
“The details of how the gut has an impact on health in general have been reviewed in detail elsewhere [1,11-15] and are summarised in Figure 1.”
Human Colonic Microbiota: Ecology, Physiology and Metabolic Potential of Intestinal Bacteria
Macfarlane, G. T., & Macfarlane, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1997.11720708 · Cited by 342 · cited 1×
“The GI microbiome consists of about 10(14) bacteria that are mainly located in the large intestine [22,23].”
Assessment of Functional Gastrointestinal Disease: The Bowel Disease Questionnaire
TALLEY, N. J., PHILLIPS, S. F., WILTGEN, C. M., ZINSMEISTER, A. R., & MELTON, L. J. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62169-7 · Cited by 330 · cited 8×
“So far, great effort has been made to improve CRC prevention strategies, with variable success [114,115].”
InfluentialPASSCLAIM1?Gut health and immunity
Cummings, J. H., Antoine, J.-M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P. C., Gibson, G. R., Guarner, F., Isolauri, E., Pannemans, D., et al. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-1205-4 · Cited by 324 · cited 6×
“Markers of functionality Gastric function pH metry in the esophagus [6,7] and stomach [1-3], gastroesophageal reflux episodes (< 50/day, <60 minutes total), viscosity of the luminal content using a viscometer, stool weight (> 100 g/d, <500 g/d) and stool consistency (water content)”
InfluentialPrevention of chronic diseases: a call to action
Beaglehole, R., Ebrahim, S., Reddy, S., Voûte, J., & Leeder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61700-0 · Cited by 319
Mechanisms of Disease: the hygiene hypothesis revisited
Guarner, F., Bourdet-Sicard, R., Brandtzaeg, P., Gill, H. S., McGuirk, P., van Eden, W., Versalovic, J., Weinstock, J. V., & Rook, G. A. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0471 · Cited by 315
Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., & Fellermann, K. (2007) · Infection and Immunity · doi:10.1128/iai.01563-06 · Cited by 315 · cited 1×
“Moreover, probiotic bacteria can support the normal development of the mucosal immune system, such as through the C-C chemokine receptor 6 (CCR6) gene expressed on lamina propria lymphocytes [24] and the production of protective IgA and antimicrobial defensins such as the CCR6 ligand human b-defensin 2 (or hBD2) [105,…”
Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications
Mankertz, J., & Schulzke, J.-D. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32816aa392 · Cited by 312 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
Hoveyda, N., Heneghan, C., Mahtani, K. R., Perera, R., Roberts, N., & Glasziou, P. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-15 · Cited by 297 · cited 1×
“Probiotic intervention, however, still needs to be improved [120,121].”
The spectrum of celiac disease: epidemiology, clinical aspects and treatment
Tack, G. J., Verbeek, W. H. M., Schreurs, M. W. J., & Mulder, C. J. J. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.23 · Cited by 291 · cited 1×
“Therefore, a balanced diet that includes high vegetable and fibre content and moderate consumption of red meat to prevent colon cancer [92,93], or an individualized elimination diet in selected individuals with food intolerances, food allergy or coeliac disease [94,95], might contribute to gut health.”
Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine*
De-Souza, D. A., & Greene, L. J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000162680.52397.97 · Cited by 286 · cited 3×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
The Human Intestinal Microbiome: A New Frontier of Human Biology
Hattori, M., & Taylor, T. D. (2009) · DNA Research · doi:10.1093/dnares/dsn033 · Cited by 281
Multiple Health Behavior Research represents the future of preventive medicine
Prochaska, J. O. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.01.015 · Cited by 264 · cited 1×
“Therefore, a major effort in the future must be made to improve acceptance rates of guidelines by physicians and of screenings by the afflicted populations [116].”
Defining ‘health’ and ‘disease’
Ereshefsky, M. (2009) · Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2009.06.005 · Cited by 257 · cited 1×
“This definition, however, is based on exclusions and on more or less subjective criteria [10].”
Labus, J. S., Mayer, E. A., Chang, L., Bolus, R., & Naliboff, B. D. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31802e2f24 · Cited by 257 · cited 2×
“Moreover, scores have been developed and tested which assess particular symptoms, such as pain, using the Functional Bowel Disorder Severity Index or the Numeric Rating Scale [80,81], as well as scores that assess anxiety using the Visceral Sensitivity Index [82].”
A distinctive 'microbial signature' in celiac pediatric patients
Schippa, S., Iebba, V., Barbato, M., Di Nardo, G., Totino, V., Checchi, M., Longhi, C., Maiella, G., Cucchiara, S., & Conte, M. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-175 · Cited by 256
Traditional Chinese Medicine and Kampo: A Review from the Distant past for the Future
Yu, F., Takahashi, T., Moriya, J., Kawaura, K., Yamakawa, J., Kusaka, K., Itoh, T., Morimoto, S., Yamaguchi, N., & Kanda, T. (2006) · Journal of International Medical Research · doi:10.1177/147323000603400301 · Cited by 246 · cited 2×
““Honoured middle” (onaka) and “centre of the spiritual and physical strength” (hara) are how the Japanese describe our largest organ, the intestine, which for many Europeans is barely more than a simple digestive system which simply has to function [2].”
The Impact of Probiotic on Gut Health
Collado, M., Isolauri, E., Salminen, S., & Sanz, Y. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048437 · Cited by 244 · cited 1×
“Recently, a few trials have yielded promising but rather preliminary clinical data or surrogate marker analysis [107-109].”
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243 · cited 1×
“There is now overwhelming evidence that the intestinal microbiome is not only changed but also involved in the pathogenesis of IBS and stress-induced GI dysfunction [118,119].”
Helminths and the IBD hygiene hypothesis
Weinstock, J. V., & Elliott, D. E. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20633 · Cited by 243 · cited 1×
“This concept maintains that any disturbance of the balance between the microbiome and the mucosal immune system will lead to impairment of the GI barrier and subsequently to an increased risk to gut health and subsequent development of GI disease [53,86-88].”
A population-based twin study of functional somatic syndromes
Kato, K., Sullivan, P. F., Evengård, B., & Pedersen, N. L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003784 · Cited by 237
Lyons, A., O'Mahony, D., O'Brien, F., MacSharry, J., Sheil, B., Ceddia, M., Russell, W. M., Forsythe, P., Bienenstock, J., Kiely, B., et al. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03437.x · Cited by 233 · cited 1×
“Other groups have shown that selected bacterial strains can induce regulatory cells that protect against pathogentriggered or allergen-induced inflammation [69].”
The Role of Microbiota and Probiotics in Stress-Induced Gastrointestinal Damage
Lutgendorff, F., Akkermans, L., & Soderholm, J. (2008) · Current Molecular Medicine · doi:10.2174/156652408784533779 · Cited by 230 · cited 1×
“There is now overwhelming evidence that the intestinal microbiome is not only changed but also involved in the pathogenesis of IBS and stress-induced GI dysfunction [118,119].”
Takeda, A., Cooper, K., Bird, A., Baxter, L., Frampton, G., Gospodarevskaya, E., Welch, K., & Bryant, J. (2010) · Health Technology Assessment · doi:10.3310/hta14420 · Cited by 226
Chemoprevention of colorectal cancer: systematic review and economic evaluation
Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R., Maguire, C., Hind, D., & Tappenden, P. (2010) · Health Technology Assessment · doi:10.3310/hta14320 · Cited by 218 · cited 1×
“Chemoprevention by taking aspirin, cyclooxygenase 2 inhibitors and calcium may reduce the recurrence of adenomas and/or the incidence of advanced adenomas in individuals with an increased risk of CRC, and taking aspirin may reduce the incidence of CRC in the general population [98].”
Molecular Modulation of Intestinal Epithelial Barrier: Contribution of Microbiota
Sharma, R., Young, C., & Neu, J. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/305879 · Cited by 214 · cited 2×
“The details of how the gut has an impact on health in general have been reviewed in detail elsewhere [1,11-15] and are summarised in Figure 1.”
Scanlan, P. D., Shanahan, F., & Marchesi, J. R. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-79 · Cited by 206 · cited 1×
“Moreover, apart from human gene polymorphisms, bacterial genetic variations have to be considered in this context [65].”
Microbiota-stimulated immune mechanisms to maintain gut homeostasis
Chung, H., & Kasper, D. L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.008 · Cited by 205 · cited 2×
“The details of how the gut has an impact on health in general have been reviewed in detail elsewhere [1,11-15] and are summarised in Figure 1.”
Review article: bacterial translocation in the critically ill – evidence and methods of prevention
GATT, M., REDDY, B. S., & MACFIE, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03174.x · Cited by 201 · cited 2×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198 · cited 1×
“In recent publications, high-fat as well as high-fructose diets have been shown to disturb the GI barrier and, in this way, to induce fatty liver disease and subclinical inflammatory conditions associated with metabolic disturbances [35,89,90].”
Therapeutic manipulation of immune tolerance in allergic disease
Akdis, M., & Akdis, C. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2653 · Cited by 195 · cited 12×
“The details of these mechanisms are not fully understood, but it is clear from numerous observations that loss of bacterial challenge and loss of immune tolerance results in severe hypersensitivity reactions, leading to chronic inflammatory states such as allergic disease, autoimmune disease and IBD [53,54].”
InfluentialProbiotics and intestinal health effects: a clinical perspective
Marteau, P., Seksik, P., & Jian, R. (2002) · British Journal of Nutrition · doi:10.1079/bjn2002629 · Cited by 184 · cited 1×
“Recently, a few trials have yielded promising but rather preliminary clinical data or surrogate marker analysis [107-109].”
Hahn, B. A., Kirchdoerfer, L. J., Fullerton, S., & Mayer, E. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00160.x · Cited by 178 · cited 1×
“Probably the most suitable HRQoL assessment tool is the Irritable Bowel Syndrome-Quality of Life questionnaire, because IBS is the disease entity closest to the borderline between gut health and GI disease [72].”
De Preter, V., Vanhoutte, T., Huys, G., Swings, J., De Vuyst, L., Rutgeerts, P., & Verbeke, K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00052.2006 · Cited by 178 · cited 1×
“Recently, a few trials have yielded promising but rather preliminary clinical data or surrogate marker analysis [107-109].”
Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial
Heath, E. I., Canto, M. I., Piantadosi, S., Montgomery, E., Weinstein, W. M., Herman, J. G., Dannenberg, A. J., Yang, V. W., Shar, A. O., Hawk, E., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk112 · Cited by 178
Qin, H., Zhang, Z., Hang, X., & Jiang, Y. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-63 · Cited by 175
Mucosal flora in Crohn's disease and ulcerative colitis - an overview.
Swidsinski, A. V., Loening-Baucke, V. A., & Herber, A. (2009) · PubMed · Cited by 174
Gut barrier function in malnourished patients
Welsh, F. K. S., Farmery, S. M., MacLennan, K., Sheridan, M. B., Barclay, G. R., Guillou, P. J., & Reynolds, J. V. (1998) · Gut · doi:10.1136/gut.42.3.396 · Cited by 167 · cited 3×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Mechanisms of Disease: defensins in gastrointestinal diseases
Wehkamp, J., Fellermann, K., Herrlinger, K. R., Bevins, C. L., & Stange, E. F. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0265 · Cited by 164 · cited 2×
“To achieve the defence of the host against luminal bacteria and other potentially harmful substances, the GI immune system is equipped with specific tools, such as the plasma cell-dependent immunoglobulin A (IgA) defence system, goblet cell-derived mucus production and the synthesis of antimicrobial peptides such as d…”
Wapenaar, M. C., Monsuur, A. J., van Bodegraven, A. A., Weersma, R. K., Bevova, M. R., Linskens, R. K., Howdle, P., Holmes, G., Mulder, C. J., Dijkstra, G., et al. (2008) · Gut · doi:10.1136/gut.2007.133132 · Cited by 163 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Spruss, A., & Bergheim, I. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.05.006 · Cited by 162 · cited 3×
“In recent publications, high-fat as well as high-fructose diets have been shown to disturb the GI barrier and, in this way, to induce fatty liver disease and subclinical inflammatory conditions associated with metabolic disturbances [35,89,90].”
Drossman, D. A., Li, Z., Toner, B. B., Diamant, N. E., Creed, F. H., Thompson, D., Read, N. W., Babbs, C., Barreiro, M., Bank, L., et al. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064187 · Cited by 161
Colonic Bacterial Flora: Changing Understandings in the Molecular Age
Mai, V., & Morris, J. G. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.459 · Cited by 159 · cited 1×
“The GI microbiome consists of about 10(14) bacteria that are mainly located in the large intestine [22,23].”
Jacobs, D., Gaudier, E., Duynhoven, J., & Vaughan, E. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048383 · Cited by 157 · cited 3×
“The expression ‘gut health’ lacks clear definition in the scientific literature, although it has been used repeatedly in human medicine [4-7] and in animal health [8,9].”
Möndel, M., Schroeder, B. O., Zimmermann, K., Huber, H., Nuding, S., Beisner, J., Fellermann, K., Stange, E. F., & Wehkamp, J. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.77 · Cited by 157 · cited 1×
“Moreover, probiotic bacteria can support the normal development of the mucosal immune system, such as through the C-C chemokine receptor 6 (CCR6) gene expressed on lamina propria lymphocytes [24] and the production of protective IgA and antimicrobial defensins such as the CCR6 ligand human b-defensin 2 (or hBD2) [105,…”
Swidsinski, A., Sydora, B. C., Doerffel, Y., Loening-Baucke, V., Vaneechoutte, M., Lupicki, M., Scholze, J., Lochs, H., & Dieleman, L. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20163 · Cited by 155 · cited 1×
“Under normal conditions, these mechanisms also prevent direct contact between commensal bacteria and the GI epithelium [52].”
Muise, A. M., Walters, T. D., Glowacka, W. K., Griffiths, A. M., Ngan, B.-Y., Lan, H., Xu, W., Silverberg, M. S., & Rotin, D. (2009) · Gut · doi:10.1136/gut.2008.175117 · Cited by 152 · cited 1×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Mai, V., & Draganov, P. V. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.81 · Cited by 148 · cited 2×
“Intestinal Infectious diarrhoea [26,36] Inflammatory bowel disease [130-132] Coeliac disease [131] Irritable bowel syndrome [133] Inflammatory bowel disease [138,139] Coeliac disease [140] Irritable bowel syndrome [141,142]”
Kim, Y., Kim, S. H., Whang, K. Y., Kim, Y. J., & Oh, S. (2008) · PubMed · Cited by 142
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis
Zhang, L., Ren, X., Alt, E., Bai, X., Huang, S., Xu, Z., Lynch, P. M., Moyer, M. P., Wen, X.-F., & Wu, X. (2010) · Nature · doi:10.1038/nature08871 · Cited by 141 · cited 1×
“Other chemopreventive strategies, such as retinoid-based therapy and tumour necrosis factor-related, apoptosis-inducing ligand in patients at risk for CRC, are based on animal experiments and need to be confirmed in human studies [99].”
Stolper, E., van Bokhoven, M., Houben, P., Van Royen, P., van de Wiel, M., van der Weijden, T., & Jan Dinant, G. (2009) · BMC Family Practice · doi:10.1186/1471-2296-10-17 · Cited by 140
The human gut microbiome: Implications for future health care
Kinross, J. M., von Roon, A. C., Holmes, E., Darzi, A., & Nicholson, J. K. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0075-y · Cited by 137 · cited 2×
“The tools required to answer such questions are rapidly advancing and have already allowed adequate analysis in research settings and perhaps also in the near future in health care settings [1,27].”
Commensal Microbiota and CD8+ T Cells Shape the Formation of Invariant NKT Cells
Wei, B., Wingender, G., Fujiwara, D., Chen, D. Y., McPherson, M., Brewer, S., Borneman, J., Kronenberg, M., & Braun, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902620 · Cited by 136 · cited 1×
“Most excitingly, recent data in germ-free and colonised mice indicate that commensal microbiota profoundly shape the invariant natural killer T-cell compartment, a major component of the host immune system, through an epigenetic mechanism [68].”
Randi, G., Edefonti, V. C., Ferraroni, M., Vecchia, C. L., & Decarli, A. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00299.x · Cited by 133 · cited 1×
“Therefore, a balanced diet that includes high vegetable and fibre content and moderate consumption of red meat to prevent colon cancer [92,93], or an individualized elimination diet in selected individuals with food intolerances, food allergy or coeliac disease [94,95], might contribute to gut health.”
Validation and normative data of health status measures in older people: the Islington study
Pettit, T., Livingston, G., Manela, M., Kitchen, G., Katona, C., & Bowling, A. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.479 · Cited by 130 · cited 1×
“The HSQ-12, in contrast to the also validated 12-item Short Form Health Survey (SF-12), can distinguish between people with and without dementia [74].”
Mechanisms of Neural Response to Gastrointestinal Nutritive Stimuli: The Gut-Brain Axis
Tsurugizawa, T., Uematsu, A., Nakamura, E., Hasumura, M., Hirota, M., Kondoh, T., Uneyama, H., & Torii, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.057 · Cited by 127 · cited 2×
“The details of how the gut has an impact on health in general have been reviewed in detail elsewhere [1,11-15] and are summarised in Figure 1.”
Irritable bowel syndrome: Novel views on the epidemiology and potential risk factors
Rey, E., & Talley, N. J. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.005 · Cited by 122 · cited 2×
“Second, marketing professionals have discovered this concept for their own specific goals [1,3].”
Thompson‐Chagoyan, O. C., Vieites, J. M., Maldonado, J., Edwards, C., & Gil, A. (2010) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2009.00961.x · Cited by 116 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Chemoprevention of Colorectal Neoplasia: The Potential for Personalized Medicine
Arber, N., & Levin, B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.012 · Cited by 116 · cited 1×
“So far, great effort has been made to improve CRC prevention strategies, with variable success [114,115].”
Appropriateness of colonoscopy in Europe (EPAGE II) – Screening for colorectal cancer
Arditi, C., Peytremann‐Bridevaux, I., Burnand, B., Eckardt, V. F., Bytzer, P. M., Agréus, L., Dubois, R., Vader, J. ‐., Froehlich, F., Pittet, V. E. H., et al. (2009) · Endoscopy · doi:10.1055/s-0028-1119626 · Cited by 115
Bär, F., Von Koschitzky, H., Roblick, U., Bruch, H. P., Schulze, L., Sonnenborn, U., Böttner, M., & Wedel, T. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01258.x · Cited by 113 · cited 9×
“Instead, the current understanding of the GI barrier is more complex, since it refers to a functional entity consisting of epithelial defence and metabolic functions, the mucosal immune system and the enteric nervous system (ENS).”
InfluentialSPIEGEL, B., BOLUS, R., HARRIS, L. A., LUCAK, S., NALIBOFF, B., ESRAILIAN, E., CHEY, W. D., LEMBO, A., KARSAN, H., TILLISCH, K., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04144.x · Cited by 112 · cited 1×
“Moreover, scores have been developed and tested which assess particular symptoms, such as pain, using the Functional Bowel Disorder Severity Index or the Numeric Rating Scale [80,81], as well as scores that assess anxiety using the Visceral Sensitivity Index [82].”
M. Ledochowski, B. W. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200451162 · Cited by 110 · cited 2×
“The first hints that CNS diseases such as hepatic encephalopathy, depression and autism spectrum disorder might be treated by modulating the GI microbiome (for example, with the prebiotic and laxative lactulose, sugar-reduced diets or antibiotics) is a further argument for the relevance of the GBA [58-60].”
Dietary Patterns and Colorectal Adenoma and Cancer Risk: A Review of the Epidemiological Evidence
Miller, P. E., Lesko, S. M., Muscat, J. E., Lazarus, P. J., & Hartman, T. J. (2010) · Nutrition and Cancer · doi:10.1080/01635580903407114 · Cited by 109 · cited 1×
“Therefore, a balanced diet that includes high vegetable and fibre content and moderate consumption of red meat to prevent colon cancer [92,93], or an individualized elimination diet in selected individuals with food intolerances, food allergy or coeliac disease [94,95], might contribute to gut health.”
ADAM, B., Liebregts, T., Saadat-Gilani, K., Vinson, B. R., & Holtmann, G. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02572.x · Cited by 107 · cited 1×
“Other disease-related GI symptom scales that have been validated are the IBS Severity Scoring System for scoring lower GI tract symptoms and the Leeds Dyspepsia Questionnaire or the Gastrointestinal Symptom profile for scoring upper GI tract symptoms [77-79].”
Genetic Approaches to Functional Gastrointestinal Disorders
Saito, Y. A., Mitra, N., & Mayer, E. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.037 · Cited by 105 · cited 1×
“Although a few IBS studies on familial associations and gene polymorphisms have suggested that genetic factors might play a role in the pathogenesis of this disease [63,64], the converse argument that genetic factors determine gut health is not justified yet.”
Impact of antibiotics on the gut microbiota of critically ill patients
Iapichino, G., Callegari, M. L., Marzorati, S., Cigada, M., Corbella, D., Ferrari, S., & Morelli, L. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47387-0 · Cited by 105 · cited 1×
“In particular, the GI barrier, and consequently gut health, will be directly altered not only by local disturbances (such as increased epithelial permeability due to infection or any loss of function of particular immune cells and their mediators) but also by any systemic burden such as reduced oxygenation in intensiv…”
The significance of the gut barrier in disease: Figure 1
Meddings, J. (2008) · Gut · doi:10.1136/gut.2007.143172 · Cited by 105 · cited 1×
“There is now ample evidence that two functional entities are key to achieving and maintaining gut health [17-20].”
Fisher, E., Boeing, H., Fritsche, A., Doering, F., Joost, H.-G., & Schulze, M. B. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508020369 · Cited by 100
The Multifaceted Influence of the Mucosal Microflora on Mucosal Dendritic Cell Responses
Strober, W. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.001 · Cited by 98 · cited 1×
“and antibodies) and innate immune cells such as macrophages and mast cells (via TLRs and other PRRs) are also involved in communication between the GI microbiome and the GI immune system so that any danger from pathogens can be recognised and also to maintain the friendly coexistence of bacteria and host in the gut [4…”
The Short‐Form Leeds Dyspepsia Questionnaire validation study
FRASER, A., DELANEY, B. C., FORD, A. C., QUME, M., & MOAYYEDI, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03233.x · Cited by 96 · cited 1×
“Other disease-related GI symptom scales that have been validated are the IBS Severity Scoring System for scoring lower GI tract symptoms and the Leeds Dyspepsia Questionnaire or the Gastrointestinal Symptom profile for scoring upper GI tract symptoms [77-79].”
Müller-Lissner, S. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00027-1 · Cited by 91 · cited 1×
“In clinical trials, overall improvement of symptoms has been assessed by using singular global questions such as the IBS Global Assessment of Improvement or the Subject’s Global Assessment of Relief, which have yielded reliable results [83,84].”
IBS: an epigenetic perspective
Dinan, T. G., Cryan, J. F., Shanahan, F., Keeling, P. W. N., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.99 · Cited by 91 · cited 1×
“In this context, it is interesting to note that IBS is now also recognised from an epigenetic perspective on the basis of animal studies and a few human data (reviewed in [67]).”
Possemiers, S., Grootaert, C., Vermeiren, J., Gross, G., Marzorati, M., Verstraete, W., & de Wiele, T. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788489159 · Cited by 91 · cited 1×
“The GI microbiome prevents colonisation by potentially pathogenic microorganisms, provides energy for the gut wall from undigested food (for example, carbohydrates and other nutrients) and it regulates the mucosal immune system, not only educating the naive infant immune system but also serving as an important source…”
The Microbes of the Intestine: An Introduction to Their Metabolic and Signaling Capabilities
Hsiao, W. W. L., Metz, C., Singh, D. P., & Roth, J. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.08.006 · Cited by 81 · cited 1×
“The GI microbiome prevents colonisation by potentially pathogenic microorganisms, provides energy for the gut wall from undigested food (for example, carbohydrates and other nutrients) and it regulates the mucosal immune system, not only educating the naive infant immune system but also serving as an important source…”
Studying the Human Gut Microbiota in the Trans-Omics Era - Focus on Metagenomics and Metabonomics
Tuohy, K., Gougoulias, C., Shen, Q., Walton, G., Fava, F., & Ramnani, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168182 · Cited by 77 · cited 2×
“To focus on new gut health parameters such as microbiome gene analysis, and to combine them with tools such as genomics and metabolomics, might become the basis for a new kind of personalised medicine that nutritionists and dieticians have been seeking for several years [4-6,85].”
The treatment of hepatic encephalopathy
Morgan, M. Y., Blei, A. T., Grüngreiff, K., Jalan, R., KIRCHEIS, G., Marchesini, G., Riggio, O., & Weißenborn, K. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9060-7 · Cited by 74
The Immunological Basis of the Hygiene Hypothesis
Pfefferle, P. I., Teich, R., & Renz, H. (2008) · Springer eBooks · doi:10.1007/978-4-431-72802-3_19 · Cited by 73 · cited 1×
“This concept maintains that any disturbance of the balance between the microbiome and the mucosal immune system will lead to impairment of the GI barrier and subsequently to an increased risk to gut health and subsequent development of GI disease [53,86-88].”
AYURVEDIC MEDICINE AND ARTHRITIS
Chopra, A. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70127-7 · Cited by 70 · cited 1×
“Systematic strategies to improve lifestyle and to avoid or reduce stress that have been validated in controlled trials are rare; however, meditative methods that often originate from traditional Chinese medicine and other Asiatic cultures (for example, ayurveda and tai-chi) are enjoying growing popularity and becoming…”
Jeong, S., Song, Y.-K., & Cho, J.-H. (2009) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.01.004 · Cited by 65 · cited 1×
“Any impairment of the GI microbiome, for example, by administration of oral antibiotics [31-33] or by an unbalanced diet such as a carbohydrate-rich diet [34,35], and SCB, (unpublished work), will affect the functionality of the host’s local defence systems.”
Ait‐belgnaoui, A., Eutamene, H., Houdeau, E., Bueno, L., Fioramonti, J., & Theodorou, V. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01280.x · Cited by 61 · cited 3×
“Moreover, experimental data have shown that probiotics, by modifying the GI microbiome, can affect both the ENS [61] and the CNS [62], which highlights the relevance of the CNS for gut health.”
Microecology, obesity, and probiotics
Tennyson, C. A., & Friedman, G. (2008) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328308dbfb · Cited by 61 · cited 1×
“Similar findings have been described by microbiologists who found that obesity risk and treatment response are associated with the particular composition of the intestinal microbiome [125,126].”
Probiotics effects on gastrointestinal function: beyond the gut?
Verdu, E. F. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01297.x · Cited by 53
Peeters, M., Hiele, M., Ghoos, Y., Huysmans, V, Geboes, K., Vantrappen, G., & Rutgeerts, P. (1994) · Gut · doi:10.1136/gut.35.10.1404 · Cited by 42 · cited 1×
“Therefore, not only permeability tests, which are known to have several serious limitations in themselves [21], but also the whole repertoire of tests recording GI functions need to be considered for the assessment of the GI barrier.”
Reliability, Validity, and Scoring of the Health Status Questionnaire-12 Version 2.0
Barry, T. L., Kaiser, K. L., & Atwood, J. R. (2007) · Journal of Nursing Measurement · doi:10.1891/106137407780851778 · Cited by 37 · cited 1×
“The Health Status Questionnaire-12 (HSQ-12) is another reliable, valid, low-cost measure of health status that was created to assess the general population [73].”
Arvola, T., Moilanen, E., Vuento, R., & Isolauri, E. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200401000-00020 · Cited by 37 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
The Gut Microbiota as a Target for Improved Surgical Outcome and Improved Patient Care
Kinross, J. K., von Roon, A. C., Penney, N. C., Holmes, E. C., Silk, D. B. A., Nicholson, J. K., & Darzi, A. W. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168119 · Cited by 35 · cited 1×
“In particular, the GI barrier, and consequently gut health, will be directly altered not only by local disturbances (such as increased epithelial permeability due to infection or any loss of function of particular immune cells and their mediators) but also by any systemic burden such as reduced oxygenation in intensiv…”
Selective Activation of Human Intestinal Mast Cells by Escherichia coli Hemolysin
Krämer, S., Sellge, G., Lorentz, A., Krueger, D., Schemann, M., Feilhauer, K., Gunzer, F., & Bischoff, S. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1438 · Cited by 34 · cited 1×
“and antibodies) and innate immune cells such as macrophages and mast cells (via TLRs and other PRRs) are also involved in communication between the GI microbiome and the GI immune system so that any danger from pathogens can be recognised and also to maintain the friendly coexistence of bacteria and host in the gut [4…”
Self-citationTraditional Chinese Medicine Based Subgrouping of Irritable Bowel Syndrome Patients
Tan, S., Tillisch, K., Bolus, R. R., Olivas, T. I., Spiegel, B. M. R., Naliboff, B. D., Chang, L., & Mayer, E. A. (2005) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x05002989 · Cited by 33 · cited 1×
“Systematic strategies to improve lifestyle and to avoid or reduce stress that have been validated in controlled trials are rare; however, meditative methods that often originate from traditional Chinese medicine and other Asiatic cultures (for example, ayurveda and tai-chi) are enjoying growing popularity and becoming…”
The Role of the Epithelial Barrier in Inflammatory Bowel Disease
Nieuwenhuis, E. E. S., & Blumberg, R. S. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-33778-4_7 · Cited by 26 · cited 1×
“There is now ample evidence that two functional entities are key to achieving and maintaining gut health [17-20].”
Ferguson, L. R., Shelling, A. N., Lauren, D. R., Heyes, J. A., & McNabb, W. C. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.05.001 · Cited by 23
Session 5: Nutrition communication The challenge of effective food risk communication
McGloin, A. F., Delaney, L. D., Hudson, E. M., & Wall, P. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109001153 · Cited by 21 · cited 1×
“therefore, we must draw more attention to the maintenance of health, and this includes gut health [110-113].”
Thierry, A., Bernasconi, E., Mercenier, A., & Corthésy, B. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03185.x · Cited by 18 · cited 1×
“Extraintestinal Allergic diseases [20,134,135] Autoimmune diseases and arthritis [17] Obesity, fatty liver disease and nonalcoholic steatohepatitis (NASH) [35,136,137] Systemic inflammatory response syndrome (SIRS) and sepsis in ICU patients [36,37] Malnutrition [40] Allergic diseases [143,144] Arthritis [145] Obesity…”
Communicating about gut health to the consumer: presenting the BENEO® Programme
Coussement, P. (2002) · British Journal Of Nutrition · doi:10.1079/bjnbjn/2002553 · Cited by 6 · cited 2×
“The use of such tools in daily practice for diagnostic purposes and for new drug development [127], together with improved communication about gut issues as proposed by several national initiatives in the United Kingdom [128], the Netherlands [129] and Germany (initiative of the Felix-Burda foundation; see http://www.”
Gut health, genetics and personalised nutrition
Johnson, I. T. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0020-y · Cited by 2
Research works printed but not linked: 26
- Nakamura, M. T. Regulation of energy metabolism by long-chain fatty acids / M. T. Nakamura, B. E. Yudell, J. J. Loor // Prog. Lipid. Res. -2014. -Vol. 53. -P. 124-144. doi.org/10.1016/j.plipres.2013.12.001 · DOI · Paper page
- Jacson, K. G. Meal fatty acids аnd postprandial vascular reactivity / K. G. Jacson, C. K. Armah, A. M. Minihane // Biochem. Soc. Trans. -2007. -Vol. 35, N 3. -P. 451-453. doi.org/10.1042/bst0350451 3. Солтанов В. В. Компьютерная программа идентификации потенциалов отдельных групп нейронов / В. В. Сол- танов, В. Е. Бурко // Новости мед.-биол. наук. -2005. -Т. 1, № 1. -C. 90-95. · DOI · Paper page
- Functional effects of β3-adrenoreceptor on pacemaker activity in intestinal cells of Cajal from the mouse colon / M. J. Wu [et al.] // Eur. J. Pharmacol. -2015. -Vol. 754. -P. 32-40. doi.org/10.1016/j.ejphar.2015.02.031 · doi:10.1016/j.ejphar.2015.02.031
- Kentish, S. J. The role of gastrointestinal vagal afferent fibres in obesity / S. J. Kentish, A. J. Page // J. Physiol. -2015. - Vol. 593, N 4. -P. 775-786. doi.org/10.1113/jphysiol.2014.278226 · DOI · Paper page
- Collins, S. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis / S. Collins, R. S. Surwit // Recent Prog. Horm. Res. -2001. -Vol. 56, N 1. -P. 309-328. doi.org/10.1210/rp.56.1.309 · DOI · Paper page
- Oh, L. H. Recent advances in the pathophysiology and Treatment of Gastroparesis / L. H. Oh, P. L. Pasricha // J. Neurogastroenterol. Motil. -2013. -Vol. 19, N 1. -P. 18-24. doi.org/10.5056/jnm.2013.19.1.18 · DOI
- Effects of gastrointestinal motility on obesity / X. Y. Fu [et al.] // Nutr. Matab. -2014. -Vol. 11, N 1. -P. 3. doi. org/10.1186/1743-7075-11-3 · DOI
- Brown, N. J. Gastrointestinal adaptation to enhanced small intestinal lipid exposure / N. J. Brown, R. D. Rumsey, N. W. Read // Gut. -1994. -Vol. 35, N 10. -P. 1409-1412. doi.org/10.1136/gut.35.10.1409 · DOI · Paper page
- A. L. Harte [et al.] // Diabetes Care. -2012. -Vol. 35, N 2. -P. 375-382. doi.org/10.2337/dc11-1593 · DOI · Paper page
- Purkayastha, S. Neuroinflammatory basis of metabolic syndrome / S. Purkayastha, D. Cai // Mol. Metab. -2013. - Vol. 2, N 4. -P. 356-363. doi.org/10.1016/j.molmet.2013.09.005 · DOI · Paper page
- Intestinal Immune Regulation as a Potential Diet-Modifiable Feature of Gut Inflammation and Autoimmunity / Br. Sonier [et al.] // Intern. Rev. Immunol. -2009. -Vol. 28, N 6. -P. 414-445. doi.org/10.3109/08830180903208329 References · DOI
- Nakamura M. T., Yudell B. E., Loor J. J. Regulation of energy metabolism by long-chain fatty acids. Progress in Lipid Research, 2014, vol. 53, pp. 124-144. doi.org/10.1016/j.plipres.2013.12.001 · DOI · Paper page
- Jacson K. G., Armah C. K., Minihane A. M. Meal fatty acids аnd postprandial vascular reactivity. Biochemical Society Transactions, 2007, vol. 35, no. 3, pp. 451-453. doi.org/10.1042/bst0350451 · DOI · Paper page
- Soltanov V. V., Burko V. E. The software for processing of electrophysiological data. Novosti mediko-biologicheskikh nauk [News of Biomedical Sciences], 2005, vol. 1, no. 1, pp. 90-95 (in Russian).
- Wu M. J., Shin D. H., Kim M. Y., Park C. G., Kim Y. D., Lee J., Park I. K., Choi S., So I., Park J. S., Jun J. Y. Functional effects of β3-adrenoreceptor on pacemaker activity in intestinal cells of Cajal from the mouse colon. European Journal of Pharmacology, 2015, vol. 754, pp. 32-40. doi.org/10.1016/j.ejphar.2015.02.031 · doi:10.1016/j.ejphar.2015.02.031
- Kentish S. J., Page A. J. The role of gastrointestinal vagal afferent fibres in obesity. The Journal of Physiology, 2015, vol. 593, no. 4, pp. 775-786. doi.org/10.1113/jphysiol.2014.278226 · DOI · Paper page
- Collins S., Surwit R. S. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Progress Hormone Research, 2001, vol. 56, no. 1, pp. 309-328. doi.org/10.1210/rp.56.1.309 · DOI · Paper page
- Oh L. H., Pasricha P. L. Recent advances in the pathophysiology and Treatment of Gastroparesis. Journal of Neurogastroenterology and Motility, 2013, vol. 19, no. 1, pp. 18-24. doi.org/10.5056/jnm.2013.19.1.18 · DOI
- Fu X. Y., Li Z., Zhang N., Yu H.-T., Wang S.-R., Liu J.-R. Effects of gastrointestinal motility on obesity. Nutrition & Metabolism, 2014, vol. 11, no. 1, pp. 3. doi.org/10.1186/1743-7075-11-3 · DOI
- Brown N. J., Rumsey R. D., Read N. W. Gastrointestinal adaptation to enhanced small intestinal lipid exposure. Gut, 1994, vol. 35, no. 10, pp. 1409-1412. doi.org/10.1136/gut.35.10.1409 · DOI · Paper page
- Harte A. L., Varma M. C., Tripathi G., McGee K. C., Al-Daghri N. M., Al-Attas O. S., Sabico S., O'Hare J. P., Ceriello A., Saravanan P., Kumar S., McTernan P. G. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Dibetic Subjects. Diabetes Care, 2012, vol. 35, no. 2, pp. 375-382. doi.org/10.2337/dc11-1593 · DOI · Paper page
- Purkayastha S., Cai D. Neuroinflammatory basis of metabolic syndrome. Molecular Metabolism, 2013, vol. 2, no. 4, pp. 356-363. doi.org/10.1016/j.molmet.2013.09.005 · DOI · Paper page
- Sonier Br., Patric Ch., Ajjikuttira P., Scott F. W. Intestinal Immune Regulation as a Potential Diet-Modifiable Feature of Gut Inflammation and Autoimmunity. International Reviews of Immunology, 2009, vol. 28, no. 6, pp. 414-445. doi. org/10.3109/08830180903208329 · DOI
- Bischoff S. C. 'Gut Health': a new objective in medicine. BMC Medicine, 2011, vol. 9, no. 1, pp. 24-31. doi. org/10.1186/1741-7015-9-24
- Soltanov V. V. Neurohumoral mechanisms of modulation of the visceral functions at systemic inflammation conditions. Novosti mediko-biologicheskikh nauk [News of Biomedical Sciences], 2011, vol. 4, no. 4, pp. 232-241 (in Russian). Информация об авторах Солтанов Владимир Всеволодович -член-коррес- пондент, д-р биол. наук, профессор, гл. науч. сотрудник. Институт физиологии НАН Беларуси (ул. Академи- ческая, 28, 220072, Минск, Республика Беларусь). E-mail: biblio@fizio.bas-net.by. Комаровская Людмила Михайловна -научный со- труд ник. Институт физиологии НАН Беларуси (ул. Ака- демическая, 28, 220072, Минск, Республика Беларусь).
- Soltanov V. V., Komarovskaya L. M. Role of adrenore- ceptors in the effects of fat on the electric activity of the stomach and the colon. Doklady Natsional'noi akademii nauk Belarusi [Doklady of the National Academy of Scien- ces of Belarus], 2017, vol. 61, no. 3, pp. 78-84 (in Russian).
Cited by
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
Self-citationShort chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
Brain-gut-microbe communication in health and disease
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00094 · Cited by 952
“In this context, supporting gut health through microbiota supplementation with a view toward positively influencing mental status represents a putative preventative strategy worth following (Bischoff, 2010).”
Celi, P., Cowieson, A. J., Fru-Nji, F., Steinert, R. E., Kluenter, A.-M., & Verlhac, V. (2017) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2017.09.012 · Cited by 475
Metadata
- Authors
- Bischoff, S. C.
- Affiliations
- University of Hohenheim (DE)
- Corresponding author
- Bischoff, Stephan C
- ORCID
- Bischoff, Stephan C
- Venue
- BMC Medicine
- Published
- 2011-03-14
- Volume
- 9
- Issue
- 1
- Pages
- 24-24
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3065426
- OpenAlex
- W2010783623
- Cited by
- 338
- References
- 147
- Citations by year
- 2026: 21 · 2025: 30 · 2024: 29 · 2023: 25 · 2022: 27 · 2021: 33 · 2020: 36 · 2019: 19 · 2018: 17 · 2017: 26 · 2016: 12 · 2015: 20 · 2014: 15 · 2013: 8 · 2012: 15
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- zvestiya of the National Academy of Sciences of Belarus (National Academy of Sciences of Belarus) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Doklady of the National Academy of Sciences of Belarus (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- gut health, gastrointestinal barrier, gut microbiota, intestinal barrier dysfunction, inflammatory bowel disease, functional gastrointestinal disorders, immune-mediated diseases, metabolic disorders, preventive medicine
- MeSH terms
- Communicable Diseases, Gastrointestinal Diseases, Humans, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.